Search research articles
Contact Us
Filters
Showing results (1-10 of 116) with videos related to
Page
of 12
Sort By:
International Journal of Molecular Sciences
|
March 13, 2024
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics"
Rafael Coveñas
International Journal of Molecular Sciences
|
November 9, 2024
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics: 2nd Edition"
Rafael Coveñas
International Journal of Molecular Sciences
|
December 11, 2025
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics: Third Edition"
Rafael Coveñas
Histology and Histopathology
|
February 19, 2014
Cancer progression and substance P
Rafael Coveñas, Miguel Muñoz
Expert Opinion on Therapeutic Patents
|
May 14, 2020
Neurokinin receptor antagonism: a patent review (2014-present)
Miguel Muñoz, Rafael Coveñas
Journal of Clinical Medicine
|
June 5, 2020
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
Miguel Muñoz, Rafael Coveñas
Expert Opinion on Drug Safety
|
May 28, 2013
Safety of neurokinin-1 receptor antagonists
Miguel Muñoz, Rafael Coveñas
Anti-Cancer Agents in Medicinal Chemistry
|
April 26, 2018
Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic Approach
Miguel Muñoz, Rafael Coveñas
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
|
August 5, 2016
Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: A new approach
Miguel Muñoz, Rafael Coveñas
Peptides
|
August 13, 2013
Involvement of substance P and the NK-1 receptor in cancer progression
Miguel Muñoz, Rafael Coveñas
Page
of 12
Search research articles
Search
Showing results (1-10 of 116) with videos related to
Sort By:
Page
of 12
International Journal of Molecular Sciences
|
March 13, 2024
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics"
Rafael Coveñas
International Journal of Molecular Sciences
|
November 9, 2024
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics: 2nd Edition"
Rafael Coveñas
International Journal of Molecular Sciences
|
December 11, 2025
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics: Third Edition"
Rafael Coveñas
Histology and Histopathology
|
February 19, 2014
Cancer progression and substance P
Rafael Coveñas, Miguel Muñoz
Expert Opinion on Therapeutic Patents
|
May 14, 2020
Neurokinin receptor antagonism: a patent review (2014-present)
Miguel Muñoz, Rafael Coveñas
Journal of Clinical Medicine
|
June 5, 2020
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
Miguel Muñoz, Rafael Coveñas
Expert Opinion on Drug Safety
|
May 28, 2013
Safety of neurokinin-1 receptor antagonists
Miguel Muñoz, Rafael Coveñas
Anti-Cancer Agents in Medicinal Chemistry
|
April 26, 2018
Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic Approach
Miguel Muñoz, Rafael Coveñas
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
|
August 5, 2016
Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: A new approach
Miguel Muñoz, Rafael Coveñas
Peptides
|
August 13, 2013
Involvement of substance P and the NK-1 receptor in cancer progression
Miguel Muñoz, Rafael Coveñas
Page
of 12